Abstract:Highlights • Nanoparticle-based drug delivery devices may be useful for cancer treatment due to passive drug transfer. • Mesoporous silica and poly amid amine dendrimer nanoparticles are attractive for cancer treatment. • Mesoporous silica nanoparticles sustained the release of the 5-fluorouracil in both acidic and neutral conditions. • The release of 5-fluorouracil nanoparticles is controlled and influenced by pH changes. Modern nanomedicine delivers drugs to malfunctioning cells. Several synthetic processes can change the shape, particle size, polydispersity index, surface area, and porosity of mesoporous silica nanoparticles (MSNs). Polyamidoamine (PAMAM) dendrimers are attractive polymers with circular forms, uniform distribution, well-structured branching, internal cavities, and surface terminal groups. The objective of this study is to deliver 5-fluorouracil (5-FU) as passive targeting to carcinogen cells via MSN-PAMAM-G3 nanoparticles. This study involved the direct and adaptable synthesis of MSN as the core vehicle, together with third-generation PAMAM dendrimers as the vehicle shell, with the goal of delivering the 5-FU in a targeted and controllable manner. Tetraethyl orthosilicate (TEOS) and cetyltrimethylammonium bromide (CTAB) are used as templates to make the center nanoparticle. Methyl acrylate (MA) and ethylenediamine (EDA) are monomers that cause the formation of branches in PAMAM. The obtained particles were fully characterized in terms of particle size, polydispersity index, zeta potential, thermal behavior, morphology, pore diameter, pore volume, and specific surface area. The particle size of MSN-PAMAM-G3s showed around 187.71 ± 3.97 nm, with a polydispersity index of 0.17 ± 0.01 and zeta potential of 32.17 ± 1.30 mV. By reducing the ratio of drug to vehicle from 1 to 0.25, a significant increase in the EE% of 5-FU from 21.36 ± 0.70 to 43.12 ± 0.67 was observed. The release of 5-FU from the vehicle (5-FU@MSN and 5-FU@MSN-PAMAM-G3) was shown to be considerably higher in an acidic medium (pH = 5.5) in comparison to a neutral medium (pH = 7.4) (P-value<0.05). Furthermore, in both acidic and neutral conditions, 5-FU release was sustained from the vehicle rather than the 5-FU solution. Our research revealed that the MSN-PAMAM-G3 nanoparticles effectively regulated the encapsulation and release of 5-FU, providing pH-sensitive and sustained medication delivery. It is asserted that this nanocarrier has the potential to effectively deliver 5-FU to cancer cells. Graphical abstract Download: Download high-res image (203KB) Download: Download full-size image

Desilylation Induced by Metal Fluoride Nanocrystals Enables Cleavage Chemistry In Vivo

Controlled Zn2+-Triggered Drug Release by Preferred Coordination of Open Active Sites Within Functionalization Indium Metal Organic Frameworks.

Dual-Stimulus-Triggered Programmable Drug Release and Luminescent Ratiometric Ph Sensing from Chemically Stable Biocompatible Zinc Metal-Organic Framework.

Cell‐Penetrating Poly(disulfide) Assisted Intracellular Delivery of Mesoporous Silica Nanoparticles for Inhibition of Mir‐21 Function and Detection of Subsequent Therapeutic Effects

Polytonic Drug Release via Multi-Hierarchical Microstructures Enabled by Nano-Metamaterials

Reduction-Triggered Transformation of Disulfide-Containing Micelles at Chemically Tunable Rates.

The Intracellular Controlled Release from Bioresponsive Mesoporous Silica with Folate As Both Targeting and Capping Agent

A confined crosslinking strategy towards an intelligent organosilica-micellar hybrid drug delivery system

FA-BSA gated redox-triggered hollow mesoporous silica hybrid nanocapsule delivery system

PEI fluorination reduces toxicity and promotes liver-targeted siRNA delivery

Exploring Intracellular Fate of Drug Nanocrystals with Crystal-Integrated and Environment-Sensitive Fluorophores

Fluorine Substitution Tunes the Nanofiber Chirality of Supramolecular Hydrogels to Promote Cell Adhesion and Proliferation

Cyclodextrin metal-organic framework@SiO2 nanocomposites for poorly soluble drug loading and release

Cancer Therapy and Fluorescence Imaging Using the Active Release of Doxorubicin from MSPs/Ni-LDH Folate Targeting Nanoparticles

Highly Water-Soluble Luminescent Silica-Coated Cerium Fluoride Nanoparticles Synthesis, Characterizations, and In Vitro Evaluation of Possible Cytotoxicity

Transformable liquid-metal nanomedicine

In Situ Synthesis of FeOCl in Hollow Dendritic Mesoporous Organosilicon for Ascorbic Acid-Enhanced and MR Imaging-Guided Chemodynamic Therapy in Neutral pH Conditions

Biomimetic Nucleation of Metal–Organic Frameworks on Silk Fibroin Nanoparticles for Designing Core–Shell-Structured pH-Responsive Anticancer Drug Carriers

Gold(III)-Induced Amide Bond Cleavage In Vivo: A Dual Release Strategy via π-Acid Mediated Allyl Substitution

Synthesis and characterization of mesoporous silicate as core and low generation polyamidoamine dendrimer as shell for delivery of 5-fluorouracil from their nano complex

Dehydrofluorination as a Residue-Free Selective Route to C–C Bond Formation at Metal Surfaces